InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2026-05-08 16:59:21 ET · period of report 2026-05-07 · accession 0001856369-26-000015 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-05-08 16:59 2026-05-07 RXRX Gibson Christopher Dir C - Cnv Deriv $0.00 +60.0K 966.6K +7% $0
DT 2026-05-08 16:59 2026-05-07 RXRX Gibson Christopher Dir S - Sale $3.37 -40.0K 926.6K -4% -$134.8K
DT 2026-05-08 16:59 2026-05-07 RXRX Gibson Christopher Dir G - Gift $0.00 -20.0K 906.6K -2% $0
DT 2026-05-08 16:59 2026-05-07 RXRX Gibson Christopher Dir C - Cnv Deriv $0.00 -60.0K 4.34M -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-05-07 C A 60,000 $0.00 966,556 D — — (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
2 Common Class A Common Stock 2026-05-07 S D 40,000 $3.37 926,556 D — — (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
3 Common Class A Common Stock 2026-05-07 G D 20,000 $0.00 906,556 D — — (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
4 Derivative Class B Common Stock 2026-05-07 C D 60,000 $0.00 4,343,334 D $0.00 · — to — 60,000 Class A Common Stock (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.